Literature DB >> 26182139

A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy.

Hideaki Miura1, Masayoshi Ijichi2, Yoshitaka Ando3, Korenobu Hayama3, Kuniko IIhara4, Haruki Yamada3, Yasutsugu Bandai2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) usually occurs in patients with metabolic syndrome. However, it can develop in relation with pancreaticoduodenectomy (PD) independent of insulin resistance. NAFLD/NASH potentially progresses to liver cirrhosis and subsequent end-stage liver disease, but in general the disease progression is very slow. We here report the case of a 57-year-old Japanese woman who underwent PD for pancreatic head cancer, subsequent to which she developed rapidly progressive NASH without prior liver diseases, resulting in death due to hepatic failure 5 months after PD. Marked body weight loss was a distinguishing clinical feature. Severe malnutrition induced by pancreatic exocrine insufficiency, postoperative eating disorder and exacerbation of diabetes mellitus were thought to be etiologically associated with the rapid progression of her disease. This case suggests the necessity of close hepatic surveillance as well as nutritional evaluation followed by prophylactic pancreatic enzyme replacement and nutritional supply after PD.

Entities:  

Keywords:  Diabetes mellitus (DM); Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Pancreatic cancer; Pancreatic exocrine deficiency; Pancreaticoduodenectomy (PD)

Year:  2013        PMID: 26182139     DOI: 10.1007/s12328-013-0421-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  21 in total

Review 1.  Nonalcoholic fatty liver disease: an agenda for clinical research.

Authors:  Zobair M Younossi; Anna Mae Diehl; Janus P Ong
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

3.  Severe steatosis resulted from anorexia nervosa leading to fatal hepatic failure.

Authors:  Michinori Sakada; Atsushi Tanaka; Daisuke Ohta; Motoe Takayanagi; Tomoyuki Kodama; Koyu Suzuki; Kazuaki Inoue; Yoshiyuki Fujita; Masataka Maruyama
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 4.  Nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Giulio Marchesini; Rebecca Marzocchi; Federica Agostini; Elisabetta Bugianesi
Journal:  Curr Opin Lipidol       Date:  2005-08       Impact factor: 4.776

5.  Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection.

Authors:  Yasuhiro Murata; Shugo Mizuno; Hiroyuki Kato; Masashi Kishiwada; Ichiro Ohsawa; Takashi Hamada; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Keisuke Nishimura; Kazuo Fukutome; Shuji Isaji
Journal:  Clin J Gastroenterol       Date:  2011-06-10

6.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

7.  [Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer].

Authors:  Hiroshi Tanaka; Hiroshi Takamori; Shin-ichiro Eto; Nobuyuki Ozaki; Shin-ichi Akaboshi; Osamu Nakahara; Satoshi Ida; Satoshi Furuhashi; Shinya Abe; Kei Horino; Toru Beppu; Hideo Baba
Journal:  Gan To Kagaku Ryoho       Date:  2010-09

8.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

9.  Severe acute liver damage in anorexia nervosa: two case reports.

Authors:  Carmela De Caprio; Alessia Alfano; Ignazio Senatore; Luigi Zarrella; Fabrizio Pasanisi; Franco Contaldo
Journal:  Nutrition       Date:  2006-05       Impact factor: 4.008

10.  Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy.

Authors:  Eun Hui Sim; Jung Hyun Kwon; Se Young Kim; Seung Min Jung; Lee-So Maeng; Jeong Won Jang; Kyu Won Chung
Journal:  Clin Mol Hepatol       Date:  2012-12-21
View more
  3 in total

1.  Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition.

Authors:  Jia-Huei Tsai; Linda D Ferrell; Vivian Tan; Matthew M Yeh; Monika Sarkar; Ryan M Gill
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

2.  Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis.

Authors:  Alex S Hong; Naveed Sarwar; Robert D Goldin; Ameet Dhar; Lucia A Possamai
Journal:  Cureus       Date:  2022-07-05

3.  Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis.

Authors:  Amy E McGhee-Jez; Inna Chervoneva; Misung Yi; Amisha Ahuja; Ritu Nahar; Samik Shah; Rebecca Loh; Sarah Houtmann; Rashesh Shah; Charles J Yeo; Harish Lavu; Steven J Cohen; Dina Halegoua-DeMarzio; Atrayee Basu Mallick
Journal:  J Pancreat Cancer       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.